Syndax Pharmaceuticals, Inc. (SNDX)

Syndax Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	252.25	172.35	23.68	-	-	139.71
Revenue Growth	223.68%	627.84%	-	-	-	9109.56%
Cost of Revenue	272.45	265.75	242.47	163.03	118.5	-
Gross Profit	-20.2	-93.4	-218.79	-163.03	-118.5	139.71
Selling, General & Admin	173.97	179.68	120.88	66.92	33.26	25.24
Research & Development	-	-	-	-	-	88.25
Operating Expenses	173.97	179.68	120.88	66.92	33.26	113.49
Operating Income	-194.17	-273.08	-339.67	-229.95	-151.76	26.22
Interest Expense	-42.4	-33.79	-4.93	-0.21	-3.14	-1.9
Interest & Investment Income	16.9	22.73	26.09	21.16	5.87	0.4
Other Non Operating Income (Expenses)	-1.1	-1.28	-0.25	-0.36	-0.32	0.2
Pretax Income	-220.77	-285.42	-318.76	-209.36	-149.34	24.93
Net Income	-220.77	-285.42	-318.76	-209.36	-149.34	24.93
Net Income to Common	-220.77	-285.42	-318.76	-209.36	-149.34	24.93
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	88	87	86	70	61	52
Shares Outstanding (Diluted)	88	87	86	70	61	54
Shares Change	1.95%	1.17%	21.67%	15.82%	13.31%	29.81%
EPS (Basic)	-2.51	-3.29	-3.72	-2.98	-2.46	0.48
EPS (Diluted)	-2.51	-3.29	-3.72	-2.98	-2.46	0.46
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Free Cash Flow	-220.87	-323.17	-274.9	-160.6	-133.68	29
Free Cash Flow Per Share	-2.52	-3.73	-3.21	-2.28	-2.20	0.54
Gross Margin	-8.01%	-54.19%	-	-	-	100.00%
Operating Margin	-76.98%	-158.45%	-1434.43%	-	-	18.77%
Profit Margin	-87.52%	-165.60%	-1346.11%	-	-	17.84%
Free Cash Flow Margin	-87.56%	-187.50%	-1160.91%	-	-	20.76%
EBITDA	-194.16	-273.08	-339.66	-229.94	-151.72	26.26
EBITDA Margin	-76.97%	-158.44%	-	-	-	18.80%
D&A For EBITDA	0.01	0.01	0.01	0.01	0.03	0.04
EBIT	-194.17	-273.08	-339.67	-229.95	-151.76	26.22
EBIT Margin	-76.98%	-158.45%	-	-	-	18.77%
Revenue as Reported	252.25	172.35	23.68	-	-	139.71
Advertising Expenses	-	14.4	7.3	6.1	1.5	-

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Apr 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 31, 2026

Data Sources Report a data error